[Inhibition of lactation by N-(D-6-methyl-8-isoergolin-1-yl)-N',N'-diethylurea (VUFB-6638)].
D000284:Administration, Oral; D000818:Animals; D001835:Body Weight; D004357:Drug Synergism; D004873:Ergolines / Q000008:administration & dosage / Q000494:pharmacology*; D005260:Female; D007774:Lactation / Q000187:drug effects*; D007928:Lethal Dose 50; D008090:Lisuride / Q000031:analogs & derivatives; D010121:Oxytocin / Q000494:pharmacology; D011247:Pregnancy; D011388:Prolactin / Q000494:pharmacology; D014508:Urea / Q000008:administration & dosage / Q000494:pharmacology
D004873:Ergolines; C006208:dironyl; D010121:Oxytocin; D014508:Urea; D011388:Prolactin; D008090:Lisuride
Laktationshemmende Wirkung von N-(D-6-Methyl-8-isoergolin-1-yl)-N',N'-diäthylharnstoff (VUFB-6638)